SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020219
Filing Date
2021-08-16
Accepted
2021-08-16 16:46:19
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 988653
2 ex10-1.htm EX-10.1 155980
3 ex31-1.htm EX-31.1 15141
4 ex31-2.htm EX-31.2 15251
5 ex32-1.htm EX-32.1 6685
6 ex32-2.htm EX-32.2 7121
7 form10-q_001.jpg GRAPHIC 3758
  Complete submission text file 0001493152-21-020219.txt   5018971

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE mslp-20210630.xsd EX-101.SCH 36282
9 XBRL CALCULATION FILE mslp-20210630_cal.xml EX-101.CAL 51233
10 XBRL DEFINITION FILE mslp-20210630_def.xml EX-101.DEF 166053
11 XBRL LABEL FILE mslp-20210630_lab.xml EX-101.LAB 305771
12 XBRL PRESENTATION FILE mslp-20210630_pre.xml EX-101.PRE 237760
13 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 678034
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53166 | Film No.: 211179237
SIC: 2834 Pharmaceutical Preparations